Hippo Effector YAP regulates Autophagy key effector p62 in Lung Adenocarcinoma
C. Chung (Daejeon, Republic of Korea), J. Kim (Daejeon, Republic of Korea), D. Park (Daejeon, Republic of Korea), D. Lee (Daejeon, Republic of Korea), J. Lee (Daejeon, Republic of Korea), H. Park (Daejeon, Republic of Korea), D. Kang (Daejeon, Republic of Korea), Y. Kim (Daejeon, Republic of Korea)
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Chung (Daejeon, Republic of Korea), J. Kim (Daejeon, Republic of Korea), D. Park (Daejeon, Republic of Korea), D. Lee (Daejeon, Republic of Korea), J. Lee (Daejeon, Republic of Korea), H. Park (Daejeon, Republic of Korea), D. Kang (Daejeon, Republic of Korea), Y. Kim (Daejeon, Republic of Korea). Hippo Effector YAP regulates Autophagy key effector p62 in Lung Adenocarcinoma. 4685
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: